.Pharmacolibrary.Drugs.ATC.L.L01XX35 .Pharmacolibrary.Drugs.ATC.L.L01XX35| name: | Anagrelide | |
| ATC code: | L01XX35 | |
| route: | oral | |
| compartments: | 2 | |
| dosage: | 1 | mg |
| volume of distribution: | 20 | L |
| clearance: | 30 | L/h |
| other parameters in model implementation | ||
Anagrelide is a phosphodiesterase 3 (PDE3) inhibitor used for the treatment of essential thrombocythemia (ET) to reduce elevated platelet counts and the risk of thrombosis. It is approved and utilized clinically for this indication.
Pharmacokinetic parameters reported for healthy adults and patients with essential thrombocythemia after oral administration.